42nd week of 2020 patent applcation highlights part 8 |
Patent application number | Title | Published |
20200323821 | PYRROLE COMPOUNDS | 2020-10-15 |
20200323822 | IMIDAZOLE-BASED COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS | 2020-10-15 |
20200323823 | METHODS FOR THE TREATMENT OF DEPRESSION | 2020-10-15 |
20200323824 | NOVEL SOLID FORMS OF BENDAMUSTINE HYDROCHLORIDE | 2020-10-15 |
20200323825 | COMPOUNDS AND METHODS FOR TREATING AN EPILEPTIC DISORDER | 2020-10-15 |
20200323826 | SUSTAINED-RELEASE PREPARATION COMPOSITION FOR ANIMALS | 2020-10-15 |
20200323827 | ITE FOR CANCER INTERVENTION AND ERADICATION | 2020-10-15 |
20200323828 | METHODS OF TREATING BEHAVIOR ALTERATIONS | 2020-10-15 |
20200323829 | Inhibitors of Mitochondrial Fission | 2020-10-15 |
20200323830 | TREATMENT OF VIRAL HEMORRHAGIC FEVERS WITH ETORICOXIB | 2020-10-15 |
20200323831 | LPT-723 AND IMMUNE CHECKPOINT INHIBITOR COMBINATIONS AND METHODS OF TREATMENT | 2020-10-15 |
20200323832 | Method of Treating Focal Segmental Glomerulosclerosis | 2020-10-15 |
20200323833 | HYDROPHOBIC ACID ADDITION SALTS | 2020-10-15 |
20200323834 | HYDROPHOBIC ACID ADDITION SALTS AND PHARMACEUTICAL FORMULATIONS THEREOF | 2020-10-15 |
20200323835 | TREATMENT FOR DOPAMINERGIC DISORDERS | 2020-10-15 |
20200323836 | SELECTIVE SEROTONIN 2A/2C RECEPTOR INVERSE AGONISTS AS THERAPEUTICS FOR NEURODEGENERATIVE DISEASES | 2020-10-15 |
20200323837 | METHODS AND COMPOSITIONS FOR THE ANTIVIRAL USE OF SYNTHETIC LYSINE ANALOGS AND MIMETICS | 2020-10-15 |
20200323838 | LENALIDOMIDE IMMEDIATE RELEASE FORMULATIONS | 2020-10-15 |
20200323839 | METHODS AND COMPOSITIONS FOR TREATMENT OF DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION | 2020-10-15 |
20200323840 | MULTI-PHASE DELIVERY COMPOSITIONS AND PRODUCTS INCORPORATING SUCH COMPOSITIONS | 2020-10-15 |
20200323841 | OPHTHALMIC FORMULATIONS AND USES THEREOF | 2020-10-15 |
20200323842 | CARBAMOYL CYCLOHEXANE DERIVATIVES FOR TREATING AUTISM SPECTRUM DISORDER | 2020-10-15 |
20200323843 | USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF VIRAL INFECTION CAUSED BY CORONAVIRUS | 2020-10-15 |
20200323844 | COMPOSITIONS AND METHODS OF USING NINTEDANIB FOR TREATING OCULAR DISEASES WITH ABNORMAL NEOVASCULARIZATION | 2020-10-15 |
20200323845 | LIPOSOMAL CIPROFLOXACIN FORMULATIONS WITH ACTIVITY AGAINST NON-TUBERCULOUS MYCOBACTERIA | 2020-10-15 |
20200323846 | COMPOSITIONS AND METHODS FOR PREPARING AND USING MITOCHONDRIAL UNCOUPLERS | 2020-10-15 |
20200323847 | IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERAZINE-1-CARBONYL)-4-FLUORO-BENZYL]-2H-P- HTHALAZIN-1-ONE | 2020-10-15 |
20200323848 | METHODS OF USE AND PHARMACEUTICAL COMBINATIONS OF HDAC INHIBITORS WITH BET INHIBITORS | 2020-10-15 |
20200323849 | COMBINATIONS OF HISTONE DEACETYLASE INHIBITORS AND IMMUNOMODULATORY DRUGS | 2020-10-15 |
20200323850 | PYRIMIDINE DERIVATIVE KINASE INHIBITORS | 2020-10-15 |
20200323851 | ALK5 INHIBITORS FOR TREATING MYELODYSPLASTIC SYNDROME | 2020-10-15 |
20200323852 | Compounds And Compositions As Protein Kinase Inhibitors | 2020-10-15 |
20200323853 | Compositions, Systems, And Methods For Generating Inner Ear Hair Cells For Treatment Of Hearing Loss | 2020-10-15 |
20200323854 | THERAPEUTIC COMPOUNDS AND USES THEREOF | 2020-10-15 |
20200323855 | PAK1 INHIBITORS AND USES THEREOF | 2020-10-15 |
20200323856 | COMPOSITIONS FOR TREATING SPINAL MUSCULAR ATROPHY | 2020-10-15 |
20200323857 | POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 | 2020-10-15 |
20200323858 | HETEROCYCLYLAMINES AS PI3K INHIBITORS | 2020-10-15 |
20200323859 | TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF | 2020-10-15 |
20200323860 | METHODS AND MATERIALS FOR TREATING CANCER | 2020-10-15 |
20200323861 | ANTIDIABETIC MEDICATIONS | 2020-10-15 |
20200323862 | Treatment of Cancer with TG02 | 2020-10-15 |
20200323863 | ANTICANCER TREATMENT FOR UVEAL MELANOMA | 2020-10-15 |
20200323864 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF GLIOBLASTOMA | 2020-10-15 |
20200323865 | METHODS OF TREATING CANCER | 2020-10-15 |
20200323866 | EZH2 INHIBITORS FOR TREATING LYMPHOMA | 2020-10-15 |
20200323867 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING MENTAL, BEHAVIORAL, COGNITIVE DISORDERS | 2020-10-15 |
20200323868 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING MENTAL, BEHAVIORAL, COGNITIVE DISORDERS | 2020-10-15 |
20200323869 | SUBSTITUTED PYRAZOLOAZEPIN-4-ONES AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | 2020-10-15 |
20200323870 | METHOD OF TREATING DEMENTIA | 2020-10-15 |
20200323871 | NOVEL PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S AND HUNTINGTON'S DISEASE | 2020-10-15 |
20200323872 | HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS | 2020-10-15 |
20200323873 | COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE AND PARKINSON'S DISEASE | 2020-10-15 |
20200323874 | NOVEL THIENOPYRIMIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND THERAPEUTIC USES THEREOF | 2020-10-15 |
20200323875 | MODIFIED RELEASE PHARMACEUTICAL COMPOSITION AND METHOD FOR THE TREATMENT OF MENTAL DISORDERS | 2020-10-15 |
20200323876 | NOVEL PHARMACEUTICAL COMPOSITIONS AND METHODS FOR ANXIETY, DEPRESSION AND OTHER PSYCHIATRIC DISORDERS | 2020-10-15 |
20200323877 | NOVEL PHARMACEUTICAL COMPOSITIONS AND METHODS FOR PSYCHIATRIC SYMPTOMS OF PATIENTS WITH ALZHEIMER'S DISEASE | 2020-10-15 |
20200323878 | NEFOPAM DOSAGE FORMS AND METHODS OF TREATMENT | 2020-10-15 |
20200323879 | METHODS AND COMPOSITIONS COMPRISING URSOLIC ACID AND/OR RESVERATROL FOR TREATING DIABETES, OR CANCER | 2020-10-15 |
20200323880 | METHODS OF TREATING TESTOSTERONE DEFICIENCY | 2020-10-15 |
20200323881 | SOLUBLE ESTRADIOL CAPSULE FOR VAGINAL INSERTION | 2020-10-15 |
20200323882 | PHLIP.RTM.-MEDIATED TARGETING OF CORTICOSTEROIDS TO DISEASED TISSUE | 2020-10-15 |
20200323883 | METHODS FOR TREATING AND PREVENTING VIRAL INFECTIONS | 2020-10-15 |
20200323884 | Treatment of migraine | 2020-10-15 |
20200323885 | Pharmaceutical Compositions and Their Use for Treatment of Cancer and Autoimmune Diseases | 2020-10-15 |
20200323886 | WOUND CARE FORMULATIONS WITH CLINICALLY EFFECTIVE INGREDIENT CONTENT | 2020-10-15 |
20200323887 | Pharmaceutical Combinations of Organo-Arsenoxide Compounds and mTOR Inhibitors | 2020-10-15 |
20200323888 | INHIBITORS | 2020-10-15 |
20200323889 | CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY | 2020-10-15 |
20200323890 | ORAL REHYDRATION COMPOSITION WITH OLIGOSACCHARIDES | 2020-10-15 |
20200323891 | STABLE NICOTINAMIDE RIBOSIDE COMPOSITION AND PREPARATION METHOD THEREOF | 2020-10-15 |
20200323892 | METHODS FOR TREATMENT USING SMALL MOLECULE POTASSIUM-SPARING DIURETICS AND NATRIURETICS | 2020-10-15 |
20200323893 | DETECTION OF METASTATIC DISEASE AND RELATED METHODS | 2020-10-15 |
20200323894 | COMBINATION FORMULATION OF THREE ANTIVIRAL COMPOUNDS | 2020-10-15 |
20200323895 | Compounds, Compositions, and Methods for Treating And/Or Preventing Periodontal Disease | 2020-10-15 |
20200323896 | DELIVERY OF RNA TO TRIGGER MULTIPLE IMMUNE PATHWAYS | 2020-10-15 |
20200323897 | METHODS FOR DISTRIBUTING AGENTS TO AREAS OF BRAIN | 2020-10-15 |
20200323898 | COMPOSITIONS AND METHODS FOR TREATING ACUTE MYELOID LEUKEMIA | 2020-10-15 |
20200323899 | POLYPEPTIDE HAVING THE ABILITY TO FORM CONNECTIONS OF GLUCOSYL UNITS IN ALPHA-1,3 ON AN ACCEPTOR | 2020-10-15 |
20200323900 | METHODS FOR TREATING NEUROMUSCULAR JUNCTION-RELATED DISEASES | 2020-10-15 |
20200323901 | Mutant Bordetella Strains and Methods of Use | 2020-10-15 |
20200323902 | ENHANCED hAT FAMILY TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS | 2020-10-15 |
20200323903 | DRUG RESISTANT IMMUNOTHERAPY FOR TREATMENT OF A CANCER | 2020-10-15 |
20200323904 | 3-SUBSTITUTED PIPERIDINE COMPOUNDS FOR CBL-B INHIBITION, AND USE OF A CBL-B INHIBITOR IN COMBINATION WITH A CANCER VACCINE AND/OR ONCOLYTIC VIRUS | 2020-10-15 |
20200323905 | METHODS AND COMPOSITIONS FOR MODULATING THE IMMUNE SYSTEM | 2020-10-15 |
20200323906 | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | 2020-10-15 |
20200323907 | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | 2020-10-15 |
20200323908 | METHODS OF PRODUCING ENRICHED POPULATIONS OF TUMOR REACTIVE T CELLS FROM PERIPHERAL BLOOD | 2020-10-15 |
20200323909 | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | 2020-10-15 |
20200323910 | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | 2020-10-15 |
20200323911 | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | 2020-10-15 |
20200323912 | NOVEL PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST HEAD AND NECK SQUAMOUS CELL CARCINOMA AND OTHER CANCERS | 2020-10-15 |
20200323913 | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | 2020-10-15 |
20200323914 | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | 2020-10-15 |
20200323915 | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | 2020-10-15 |
20200323916 | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | 2020-10-15 |
20200323917 | DNASE1-LIKE 3 AND ITS USE IN THERAPY | 2020-10-15 |
20200323918 | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | 2020-10-15 |
20200323919 | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | 2020-10-15 |
20200323920 | IMMUNOCOMPETENT CELL THAT EXPRESSES A CELL SURFACE MOLECULE SPECIFICALLY RECOGNIZING HUMAN MESOTHELIN, IL-7 AND CCL19 | 2020-10-15 |